Hepion Pharmaceuticals Faces Delisting Notice
Ticker: CTRVP · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Hepion Pharmaceuticals got a delisting warning from the exchange.
AI Summary
Hepion Pharmaceuticals, Inc. filed an 8-K on March 20, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as ContraVir Pharmaceuticals, Inc., is based in Edison, NJ.
Why It Matters
This filing indicates potential issues with Hepion Pharmaceuticals' compliance with stock exchange listing requirements, which could lead to the company's shares being delisted.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and investor confidence.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- ContraVir Pharmaceuticals, Inc. (company) — Former company name
- March 18, 2025 (date) — Earliest event reported date
- March 20, 2025 (date) — Filing date
- 399 Thornall Street, First Floor Edison, NJ 08837 (address) — Principal executive offices
FAQ
What specific listing rule or standard has Hepion Pharmaceuticals failed to satisfy?
The filing does not specify the exact rule or standard that Hepion Pharmaceuticals has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated March 18, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on March 20, 2025.
What was Hepion Pharmaceuticals' former company name?
Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc.
Where are Hepion Pharmaceuticals' principal executive offices located?
Hepion Pharmaceuticals' principal executive offices are located at 399 Thornall Street, First Floor Edison, NJ 08837.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).